1. The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase‐dependent mechanism. Issue 11 (13th December 2013) Authors: Jeannot, Victor; Busser, Benoît; Brambilla, Elisabeth; Wislez, Marie; Robin, Blaise; Cadranel, Jacques; Coll, Jean‐Luc; Hurbin, Amandine Journal: International journal of cancer Issue: Volume 134:Issue 11(2014:Jun. 01) Page Start: 2560 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗